Health care Device

  The global “ digestive health market ” size is expected to reach USD 71.95 billion by 2027, exhibiting a CAGR of 7.9% during the forecast period. The growing awareness regarding the prominence of dietary supplements, probiotics, and functional will have a tremendous impact on the the market, states Fortune Business Insights, in a report, titled “Digestive Health Market Size, Share & COVID-19 Impact Analysis, By Ingredient Type (Probiotics, Prebiotics, Digestive Enzymes/Food Enzymes, and Others), By Product Type (Functional Foods & Beverages, Vitamins & Dietary Supplements, and Others), By Distribution Channel (Supermarkets/Hypermarkets, Hospital Pharmacies, Online Pharmacies, and Others), and Regional Forecast, 2020-2027.” The market size stood at USD 37.93 billion in 2019. The coronavirus incident has caused massive loss and disruption to various industries across the globe. We understand that this health disaster has negatively impacted various sectors across the globe.

  The increasing prevalence of chronic diseases among the geriatric population is driving the “ Netherlands home healthcare market ”. The above information is published in a report, titled “Netherlands Home Healthcare: Market Analysis, Insights and Forecast, 2019-2026.” Fortune Business Insights in the report predicts that rising geriatric population in the Netherlands is leading to high demand for home healthcare equipment. A study by Central Bureau Statistics (CBU), it is estimated that around 3.31 million people in the Netherlands are aged above 65 years. Also, the study predicts that the number will increase by 2026. This further indicates that the adoption of home healthcare products will increase in the forthcoming years. As per the report by Fortune Business Insights, the Netherlands market was worth US$ 570.0 Mn in 2018 and is anticipated to reach US$ 1013.1 Mn by 2026. As home healthcare is a viable option and increasingly adopted by the elderly population, the market for home

  The global “ leukemia therapeutics market ” size is projected to reach USD 27.78 billion by 2027, exhibiting a CAGR of   8.1%  during the forecast period. The increasing demand for enhanced treatments for blood cancers amid the COVID-19 pandemic will accelerate the market, states Fortune Business Insights™ in its report, titled “Leukemia Therapeutics Market Size, Share & COVID-19 Impact Analysis, By Type of Leukemia (Chronic Myeloid Leukemia (CML), Chronic Lymphocytic Leukemia (CLL), Acute Lymphocytic Leukemia (ALL), Acute Myeloid Leukemia (AML), and Others), By Treatment Type (Chemotherapy, Targeted Therapy, Immunotherapy, and Others), By Route of Administration (Oral Mode and Injectable Mode), By Distribution Channels (Hospital Pharmacy, Retail Pharmacy, and Others), and Regional Forecast, 2020-2027”. Cancer patients are at a heightened risk of contracting the coronavirus and likely to experience severe effects of the infection due to their weakened immune systems. According to

  The global “ transplantation market ” size is expected to reach USD 14.67 billion by 2028, exhibiting a CAGR of 10.6% during the forecast period. The increasing awareness regarding organ donations coupled with government initiatives can have an excellent impact on the global market in the forthcoming years, states Fortune Business Insights, in a report, titled “Transplantation Market, 2021-2028.” The market size stood at USD 5.47 billion in 2020. An Overview of the Impact of COVID-19 on this Market The emergence of COVID-19 has brought the world to a standstill. We understand that this health crisis has brought an unprecedented impact on businesses across industries. However, this too shall pass. Rising support from governments and several companies can help in the fight against this highly contagious disease. There are some industries that are struggling and some are thriving. Overall, almost every sector is anticipated to be impacted by the pandemic. We are taking continuous effort

  The global “ leukemia therapeutics market ” size is projected to reach USD 27.78 billion by 2027, exhibiting a CAGR of   8.1%  during the forecast period. The increasing demand for enhanced treatments for blood cancers amid the COVID-19 pandemic will accelerate the market, states Fortune Business Insights™ in its report, titled “Leukemia Therapeutics Market Size, Share & COVID-19 Impact Analysis, By Type of Leukemia (Chronic Myeloid Leukemia (CML), Chronic Lymphocytic Leukemia (CLL), Acute Lymphocytic Leukemia (ALL), Acute Myeloid Leukemia (AML), and Others), By Treatment Type (Chemotherapy, Targeted Therapy, Immunotherapy, and Others), By Route of Administration (Oral Mode and Injectable Mode), By Distribution Channels (Hospital Pharmacy, Retail Pharmacy, and Others), and Regional Forecast, 2020-2027”. Cancer patients are at a heightened risk of contracting the coronavirus and likely to experience severe effects of the infection due to their weakened immune systems. According to

  Global   Lymphoma Treatment Market   | 2021 Global Healthcare Industry Analysis To 2028, is latest report on Global Lymphoma Treatment Industry, published by Fortune Business Insights. According to this report Global Lymphoma Treatment Market to rise at healthy Compound Annual Growth Rate by 2028. Market for Lymphoma Treatment Industry is segmented By Product Type (Lymphoma Treatment Frames and Spectacle Lenses), By Modality (Prescription and Over-the-counter) By Distribution Channel (Retail Store, Online Store, Ophthalmic Clinics), and Regional Forecast, 2019-2026 Major Lymphoma Treatment Manufacturers covered in the market report include: Takeda Pharmaceutical Company Limited AstraZeneca Bayer AG Novartis AG Kite Pharma, Inc. / Gilead Sciences, Inc. Spectrum Pharmaceuticals, Inc. Teva Pharmaceutical Industries Ltd. Bristol Myers Squibb Company Janssen Pharmaceuticals, Inc. Get Sample PDF Brochure of Lymphoma Treatment Market Report at: https://www.fortunebusinessinsights.com/enquir